M. Irfan Qureshi - Rose F. Kennedy Center for Research on Intellectual and Developmental Disabilities, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA

基本信息

浏览量：7

职业迁徙

个人简介

Though I am scientist and faculty at a central university yet remain a student of science. Having expertise in area of molecular stress physiology and proteomics of plants still keep eyes on all fields of science and all that goes around to get a scientific explanation for. Further, plant science is not the limit for me.

研究兴趣

论文共 126 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Targeting Myeloperoxidase to Reduce Neuroinflammation in X-linked Dystonia Parkinsonism

Tiziana Petrozziello,Negin Jalali Motlagh, Ranee Zara B Monsanto,Dan Lei,Micaela G Murcar,Ellen B Penney,D Cristopher Bragg,Cara Fernandez-Cerado,G Paul Legarda, Michelle Sy,Edwin Muñoz,Mark C Ang,Cid Czarina E Diesta,Can Zhang,Rudolph E Tanzi,Irfan A Qureshi,John W Chen,Ghazaleh Sadri-Vakili

CNS neuroscience & therapeuticsno. 11 (2024): e70109-e70109

引用0浏览0WOS引用

Troriluzole Exhibits Favorable Hepatic Safety Profile Across a Diverse Range of Disorders (P4-4.013)

Irfan Qureshi,Melissa Beiner,Richard Bertz,Stephen Kaplita, Rong Yang,Azim Munivar,David Stock,Victoria Wirtz,Vladimir Coric

Neurology（2024）

引用0浏览0引用

Exploring the Anti-Diabetic Mechanism of Selective Phytochemicals Identified from Gymnema Sylvestre Using TLC-UPLC-MS, Complemented by in Silico Studies

Mohammad Irfan Dar,Armiya Sultan,Sageer Abass,Kapil Dev,Rabea Parveen,Sayeed Ahmad,Mohammad Irfan Qureshi

Phytomedicine Plusno. 3 (2024): 100606-100606

引用0浏览0引用

BHV-7000, A Novel, Selective Kv7.2/7.3 Potassium Channel Activator, Demonstrates Dose-Dependent Pharmacodynamic Effects on EEG Parameters in Healthy Adults

Jason Lerner,Bharat Awsare,Heather Sevinsky,Eric Ashbrenner,Randall Killingsworth, Racheal Kendrick, Emiel Vereycken, Nigel Colenbier,Caroline Neuray, Pieter van Mierlo,Jeremy Slater,David Wyatt,Irfan Qureshi,Steven Dworetzky,Michael Bozik

NEUROTHERAPEUTICSno. 4 (2024)

引用0浏览0引用

Novel Bispecific Degrader BHV-1300 Achieves Rapid, Robust, and Selective IgG Reduction in Preclinical Models Including Nonhuman Primates (S43.004)

Anna Bunin, Seong Lee,Wes Kazmierski, Kathleen McGrath, Anne Marie Rossi, Simone Nicholson,Gene Dubowchik, Elizabeth Dierks, Neal Sharpe, David Pirman, Bruce Car,Irfan Qureshi,Vladimir Coric,David Spiegel

Neurology（2024）

引用0浏览0引用

Phase 1 Study Evaluating the Safety and Tolerability of BHV-7000, a Novel, Selective Kv7.2/7.3 Potassium Channel Activator, in Healthy Adults (P8-1.007)